neoadjuvant chemotherapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
neoadjuvant chemotherapy
May 15, 2024, 13:45 |
Blog
Sergio Cifuentes Canaval: Exciting insights from the MRI-guided optimization study in HER2+ breast cancer!
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared a post on LinkedIn:…
May 6, 2024, 20:08 |
Insight
Sergio Cifuentes: ctDNA for predicting response and prognosis in HER2-BC in NAC
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X/Twitter: "ctDNA for predicting response and…
Apr 22, 2024, 11:11 |
Insight
New Paper Alert! Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated…
Apr 20, 2024, 20:17 |
Insight
Paolo Tarantino: Tumor-infiltrating lymphocytes (TILs): not only prognostic in Triple-Negative Breast Cancer
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Tumor-infiltrating lymphocytes (TILs): not…
Apr 12, 2024, 05:34 |
Insight
Joe Lennerz: Quickly sharing a fantastic paper on tumour infiltrating lymphocytes in triple-negative breast cancer
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Quickly sharing a fantastic paper…
Apr 8, 2024, 12:20 |
Insight
Smitha Krishnamurthi: Neoadjuvant chemo (NAC) has benefit in OPTICAL and FOxTROT!
Smitha Krishnamurthi, Gastrointestinal Medical Oncologist at Cleveland Clinic, shared on X/Twitter: "Neoadjuvant chemo (NAC) has…
Apr 5, 2024, 02:23 |
Insight
Piotr J. Wysocki: OPTICAL trial - another study demonstrating the feasibility and promising efficacy of neoadjuvant chemotherapy in locally advanced colon cancer
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
All:
7
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube